Abstract
Dublin, Ireland Disclosure Information: Nothing to disclose. Disclosures outside the scope of this work: Dr le Roux is a paid board member of Novo Nordisk and GI Dynamics; is a paid consultant to and receives lecture payments from GI Dynamics, Eli Lily, Johnson and Johnson, Sanofi Aventis, Astra Zeneca, Janssen, Bristol-Myers Squibb, and Boehringer-Ingelheim; receives lecture payments from Novo Nordisk; and holds stock in Keyron. Dr le Roux’s institute receives grant funding from Ana Bio, Science Foundation Ireland, Health Research Board, Irish Research Council. Dr Sudlow has nothing to disclose.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
